Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe Europe - 12/07 10:24:08 am
8124.5 GBX   -2.85%
08:49aJefferies Lowers AstraZeneca to Hold from Buy, Cuts PT
MT
07:47aFTSE Gains, Glaxo Seen With Further Upside From Consumer Healthcare Spinoff
DJ
07:45aMarketScreener's World Press Review - December 7, 2021
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

ASTRAZENECA : Kepler Cheuvreux maintains a Buy rating

10/18/2021 | 09:32am EST

In a research note published by David Evans, Kepler Cheuvreux advises its customers to buy the stock. The target price has been lifted and is now set at GBX 9800 compared to GBX 9000 before.


© MarketScreener with dpa-AFX Analyser 2021
All news about ASTRAZENECA PLC
08:49aJefferies Lowers AstraZeneca to Hold from Buy, Cuts PT
MT
07:47aFTSE Gains, Glaxo Seen With Further Upside From Consumer Healthcare Spinoff
DJ
07:45aMarketScreener's World Press Review - December 7, 2021
07:16aEU agencies endorse mix-and-match of COVID-19 vaccines
RE
06:46aREFILE-EU health bodies recommend mix-and-match of COVID-19 vaccines
RE
06:37aJefferies Downgrades AstraZeneca to Hold From Buy
MT
06:01aANALYST RECOMMENDATIONS : AstraZeneca, Bumble, HSBC, Jack in the Box, XPO...
04:51aIonis Pharmaceuticals Agrees Strategic Collaboration With AstraZeneca to Develop and Co..
MT
04:27aAstraZeneca and Ionis sign deal to develop and commercialise eplontersen
AQ
02:54aAstraZeneca to Work with Ionis on Eplontersen Drug
DJ
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2021 35 926 M - -
Net income 2021 2 724 M - -
Net Debt 2021 24 888 M - -
P/E ratio 2021 41,0x
Yield 2021 2,54%
Capitalization 172 B 172 B -
EV / Sales 2021 5,48x
EV / Sales 2022 4,48x
Nbr of Employees 76 100
Free-Float 96,4%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | AZN | GB0009895292 | MarketScreener
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 110,91 $
Average target price 137,02 $
Spread / Average Target 23,5%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC14.19%171 675
JOHNSON & JOHNSON3.53%428 955
ROCHE HOLDING AG17.23%322 390
PFIZER, INC.44.09%288 950
NOVO NORDISK A/S65.08%245 091
ELI LILLY AND COMPANY45.45%223 321